Relapse Rate Following Azathioprine Withdrawal in Maintaining Remission for Crohn’s Disease: A Meta-Analysis

@article{French2011RelapseRF,
  title={Relapse Rate Following Azathioprine Withdrawal in Maintaining Remission for Crohn’s Disease: A Meta-Analysis},
  author={Helen French and Anthony Mark Dalzell and Ramesh Srinivasan and Wael El-Matary},
  journal={Digestive Diseases and Sciences},
  year={2011},
  volume={56},
  pages={1929-1936}
}
The duration of use of azathioprine (Aza) and 6-mercaptopurine (6-MP) for maintaining remission for Crohn’s disease is debatable. To examine whether Aza/6-MP can be safely withdrawn in patients with Crohn’s disease who have been in remission. The following databases were searched: MEDLINE (1950–September 2010), EMBASE (1980–September 2010), CINHAL (1981–September 2010), PubMed (1950–September 2010), and the Cochrane Central Register of Controlled Trials (CENTRAL). Randomised controlled and… CONTINUE READING